• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of bullwhoWHO Home PageBulletin Home PageBulletin Home PageAbout Bulletine-mail AlertSubmissions
Bull World Health Organ. Jun 2008; 86(6): 488–490.
PMCID: PMC2647477

Language: English | French | Spanish | Arabic

Cervical cancer prevention and the Millennium Development Goals

Prévention du cancer du col utérin et objectifs du Millénaire pour le développement

Prevención del cáncer cervicouterino y Objetivos de Desarrollo del Milenio

الوقاية من سرطان عنق الرحم، والمرامي الإنمائية للألفية

Abstract

The advent of new technologies such as the human papillomavirus (HPV) vaccine and HPV DNA tests – along with new insights into the appropriate use of low-resource technologies such as visual inspection of the cervix and treatment of cervical lesions with cryotherapy – have increased optimism about the potential for effective disease control in low-resource settings. Nevertheless, it is also important to ask ourselves how new health initiatives contribute, or fail to contribute, to major global undertakings such as achievement of the Millennium Development Goals (MDGs).

While reproductive health in general, and cervical cancer prevention in particular, are not explicitly mentioned among the MDGs, they are implied; and it is certain that women cannot contribute to sustainable development without good health. The question is, in what ways do scaled-up cervical cancer prevention activities, including introduction of the new HPV vaccines and increased access to precancer screening and treatment, contribute to attainment of the MDGs?

Résumé

L’avènement de nouvelles technologies, comme le vaccin contre le papillomavirus humain (HPV) et les tests ADN pour ce virus, ainsi que les nouvelles perspectives d’utilisation de technologies peu onéreuses, telles que l’examen visuel du col et le traitement des lésions cervicales par cryothérapie, amènent à être plus optimiste quant aux possibilités de lutter efficacement contre ce cancer dans les pays à faibles ressources. Néanmoins, il importe aussi de se demander comment les nouvelles initiatives sanitaires contribuent ou ne contribuent pas aux entreprises mondiales majeures comme la réalisation des objectifs du Millénaire pour le développement (OMD).

Si la santé génésique en général et la prévention du cancer du col en particulier ne sont pas explicitement mentionnées en tant qu’OMD, elles le sont implicitement et il est certain que les femmes ne peuvent participer au développement durable sans être en bonne santé. Il faut donc se demander de quelles manières le développement des activités de prévention de ce cancer, et notamment l’introduction des nouveaux vaccins contre le HPV et l’élargissement de l’accès au dépistage et au traitement précancéreux, contribue à la réalisation des OMD.

Resumen

El desarrollo de nuevas tecnologías como la vacuna contra el papilomavirus humano (PVH) y las pruebas de ADN del PVH, unido a los nuevos conocimientos sobre el uso apropiado de tecnologías de bajo costo como la inspección visual del cuello uterino y el tratamiento de las lesiones cervicouterinas mediante crioterapia, han generado un mayor optimismo respecto a las posibilidades de combatir eficazmente esa enfermedad en los entornos con pocos recursos. No obstante, es importante también determinar los mecanismos por los que las nuevas iniciativas sanitarias podrán contribuir o no al éxito de importantes proyectos mundiales, como por ejemplo los Objetivos de Desarrollo del Milenio (ODM).

Si bien en los ODM no se mencionan explícitamente la salud reproductiva en general o la prevención del cáncer cervicouterino en particular, esas dos cuestiones figuran de forma implícita en dichos objetivos, pues es obvio que las mujeres no pueden contribuir al desarrollo sostenible si no gozan de buena salud. La cuestión que se plantea es ¿cómo contribuyen al logro de los ODM las actividades expandidas de prevención del cáncer cervicouterino, incluida la introducción de las nuevas vacunas contra el PVH y el mayor acceso al cribado y tratamiento de las lesiones precancerosas?

ملخص

أدت التكنولوجيات الجديدة المبتكرة ، مثل لقاح فيروس الورم الـحُلَيْمي البشري واختبارات الدنا DNA لەذا الفيروس ، وكذلك الأفكار الجديدة المطروحة بشأن الاستخدام السليم للتكنولوجيات القليلة الموارد، مثل الفحص البصري لعنق الرحم ومعالجة آفات عنق الرحم بالبَرْد، أدى كل ذلك إلى مزيد من التفاؤل حول إمكانية مكافحة سرطان عنق الرحم بفعالية في الأماكن القليلة الموارد. وبرغم ذلك، حري بنا أن نسأل أنفسنا كيف تسەم المبادرات الصحية الجديدة، أو كيف تفشل في الإسەام في المەام العالمية الكبرى، مثل بلوغ المرامي الإنمائية للألفية.

وبرغم أن الصحة الإنجابية، بشكل عام، والوقاية من سرطان عنق الرحم، بشكل خاص، لم يرد ذكرەما صراحة في المرامي الإنمائية للألفية، إلا أنەما ذُكرا بشكل ضمني. ومن المؤكَّد أن المرأة لا يمكنەا أن تسەم في التنمية المضمونة الاستمرار بدون صحة جيدة. والسؤال المطروح الآن ەو: كيف يسەم النەوض بأنشطة الوقاية من سرطان عنق الرحم، بما في ذلك ابتكار لقاحات جديدة مضادة لفيروس الورم الـحُلَيْمي البشري وزيادة إتاحة خدمات تحري السرطان المحتمل ومعالجتە، في بلوغ المرامي الإنمائية للألفية.

Cervical cancer kills about 270 000 women every year.1 It has been called “a case study in health equity” because most (85%) of these deaths occur in the developing world. In large part, this inequity is due to the lack of cervical cancer screening programmes in those countries – the same programmes that are taken for granted in Australia, Europe and the United States of America. And since cervical cancer affects relatively young women (mortality rates climb as women enter their forties), it results in many lost years of life – 2.7 million age-weighted years of life were lost to the disease in the year 2000.2

The biggest impacts of cervical cancer are on poverty, education, and gender equity – the first three Millennium Development Goals (MDGs). Many of those who die are breadwinners and caretakers of both children and elders. For example, in sub-Saharan Africa women head one-third of all households and in Botswana, over half of the children who have lost a parent are being cared for by grandmothers – women also at risk of cervical cancer.3,4 The fabric of the family and the community is weakened significantly when these women die. This is especially true in communities also ravaged by the loss of working adults to HIV/AIDS.

In addition to the emotional trauma, cervical cancer deaths have significant economic costs over the short- and long-term (though these are seldom considered when calculating the financial burden of disease). Family members may lose work opportunities and can incur overwhelming medical costs while caring for women with cancer.5 Reduction in family income resulting from the death of a working-age adult can force remaining family decision-makers to prioritize immediate needs (food and shelter) over investment in human capital (e.g. education). As poverty increases, more children (especially girls) may be kept out of school for lack of school fees, books, or uniforms, but also so that they can contribute to family income through work. Cervical cancer can impact education in other ways as well, such as when schools lose experienced teachers to the disease. The differential economic and social impact on women and girls makes it more difficult to achieve gender equity. Finally, it should be noted that lower levels of female education are linked to decreased maternal and infant health – the focus of two other MDGs.

Developing successful cervical cancer screening and human papillomavirus (HPV) vaccination programmes opens the door to many other interventions including, for older women, opportunities to screen for other cancers and reproductive problems, and for school-age girls and boys, deworming; treatment for schistosomiasis, onchocerciasis, filariasis and trachoma; iron and/or iodine supplementation; distribution of bed nets to prevent malaria; hand washing, anti-tobacco and anti-drug education; nutritional supplementation; body-awareness education; and guidance on life choice decision-making and sexual health.6 All of these interventions are in the immediate interest of the individual, but also will help improve maternal health and result in healthier newborns when the girls who are screened become older.

Some of the benefits of improved cervical cancer prevention are obvious – the reduction in suffering and death of mature women and the grief and economic burden felt by their families. As demonstrated above, prevention programmes can also support development in other ways, including contributing to lowering poverty, increasing primary education, empowering women, improving child health and providing the basis for global partnerships. The many barriers to realizing this potential, such as the current high cost of HPV vaccine, weakness of existing cervical cancer screening and adolescent health systems, and low levels of knowledge about HPV, now are being challenged. With sufficient political will and resources, these barriers surely can be overcome in the interest of the family and the MDGs. ■

Footnotes

Funding: Support for PATH’s cervical cancer prevention initiatives comes from the Bill & Melinda Gates Foundation.

Competing interests: None declared.

References

1. Ferlay J, Bray F, Pisani P, Parkin DM. International Agency for Research on Cancer (IARC). GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide CancerBase No. 5, version 2.0. Lyon, France: IARC Press; 2004.
2. Yang BH, Bray FI, Parkin DM, Sellors JW, Zhang ZF. Cervical cancer as a priority for prevention in different world regions: an evaluation using years of life lost. Int J Cancer. 2004;109:418–24. doi: 10.1002/ijc.11719. [PMC free article] [PubMed] [Cross Ref]
3. Rural women and food security Rome, Italy: Food and Agriculture Organization of the United Nations; 1999.
4. Botswana situation analysis on orphans and vulnerable children Francistown, Botswana: United Nations Children’s Fund, Ministry of Local Government Botswana; 2003.
5. Chang S, Long SR, Kutikova L, Bowman L, Finley D, Crown WH, et al. Estimating the cost of cancer: results on the basis of claims data analyses for cancer patients diagnosed with seven types of cancer during 1999 to 2000. J Clin Oncol. 2004;22:3524–30. doi: 10.1200/JCO.2004.10.170. [PubMed] [Cross Ref]
6. Castilaw D, Wittet S. Preventing cervical cancer: unprecedented opportunities for improving women’s health. Outlook 2007;23(1). Available from: www.rho.org/files/PATH_outlook23_1_web.pdf [accessed on 8 May 2008].

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization
PubReader format: click here to try

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...